Colin Wg Fishwick

7PUBLICATIONS
23CO-AUTHORS
Biologically active moleculesNanotoxicology, health and safetyCheminformatics and quantitative structure-activity relationshipsIndustrial molecular engineering of nucleic acids and proteinsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 01, 2025
Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agents.

Jason H Gill, Jonathan D Sellars, Paul G Waddell

|Aug 03, 2022
De novo design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding region.

Kyle M Orritt, Lipeng Feng, Juliette F Newell

|Nov 15, 2021
From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor.

Lewis D Turner, Chi H Trinh, Ryan A Hubball

|Oct 19, 2019
Structure-Guided Enhancement of Selectivity of Chemical Probe Inhibitors Targeting Bacterial Seryl-tRNA Synthetase.

Ricky Cain, Ramya Salimraj, Avinash S Punekar

|May 17, 2018
X-ray and cryo-EM structures of inhibitor-bound cytochrome bc1 complexes for structure-based drug discovery.

Kangsa Amporndanai, Rachel M Johnson, Paul M O'Neill

|Dec 23, 2017
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors.

Ricky Cain, Jürgen Brem, David Zollman

Pageof 2

Frequent Collaborators

2 joint publications

Martin J McPhillie

2 joint publications

Anthony Maxwell

1 joint publications

Martine I Abboud

1 joint publications

Christopher J Schofield